Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Mbio
|
June 29, 2021
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects
Lynda Rocheleau, Geneviève Laroche, Kathy Fu, et al.
Plos Genetics
|
January 30, 2016
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier
Emma Bondy-Chorney, Tara E Crawford Parks, Aymeric Ravel-Chapuis, et al.
Open Forum Infectious Diseases
|
August 7, 2023
Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals
Marilyn Whelan, Yannick Galipeau, Nicole White-Al Habeeb, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 14, 2025
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection
Yannick Galipeau, Nicolas Castonguay, Pauline S McCluskie, et al.
The Pediatric Infectious Disease Journal
|
May 11, 2022
Antibody Seronegativity in COVID-19 RT-PCR-Positive Children
Maala Bhatt, Roger L Zemek, Ken Tang, et al.
Plos Pathogens
|
January 29, 2021
Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments
Corina M Stewart, Alexandra Phan, Yuxia Bo, et al.
CMAJ Open
|
April 13, 2022
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study
Maala Bhatt, Amy C Plint, Ken Tang, et al.
Frontiers in Public Health
|
May 24, 2024
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
Frontiers in Immunology
|
March 4, 2024
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study
Nisha D Almeida, Ian Schiller, Danbing Ke, et al.
The Lancet. Healthy Longevity
|
February 28, 2022
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study
Donald C Vinh, Jean-Philippe Gouin, Diana Cruz-Santiago, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Mbio
|
June 29, 2021
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects
Lynda Rocheleau, Geneviève Laroche, Kathy Fu, et al.
Plos Genetics
|
January 30, 2016
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier
Emma Bondy-Chorney, Tara E Crawford Parks, Aymeric Ravel-Chapuis, et al.
Open Forum Infectious Diseases
|
August 7, 2023
Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals
Marilyn Whelan, Yannick Galipeau, Nicole White-Al Habeeb, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 14, 2025
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection
Yannick Galipeau, Nicolas Castonguay, Pauline S McCluskie, et al.
The Pediatric Infectious Disease Journal
|
May 11, 2022
Antibody Seronegativity in COVID-19 RT-PCR-Positive Children
Maala Bhatt, Roger L Zemek, Ken Tang, et al.
Plos Pathogens
|
January 29, 2021
Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments
Corina M Stewart, Alexandra Phan, Yuxia Bo, et al.
CMAJ Open
|
April 13, 2022
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study
Maala Bhatt, Amy C Plint, Ken Tang, et al.
Frontiers in Public Health
|
May 24, 2024
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
Frontiers in Immunology
|
March 4, 2024
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study
Nisha D Almeida, Ian Schiller, Danbing Ke, et al.
The Lancet. Healthy Longevity
|
February 28, 2022
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study
Donald C Vinh, Jean-Philippe Gouin, Diana Cruz-Santiago, et al.
Page
of 5